{"id":8287,"date":"2025-08-09T12:07:52","date_gmt":"2025-08-09T09:07:52","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=8287"},"modified":"2025-08-09T12:07:52","modified_gmt":"2025-08-09T09:07:52","slug":"ai-enables-early-heart-failure-screening-in-primary-care","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/ai-enables-early-heart-failure-screening-in-primary-care\/","title":{"rendered":"AI Enables Early Heart Failure Screening in Primary Care"},"content":{"rendered":"
AI Enables Early Heart Failure Screening in Primary Care<\/div>\n
<\/div>\n
Published: August 4, 2025 (Based on original research published in JACC: Advances)<\/div>\n
<\/div>\n
Summary:<\/div>\n
1. Purpose of the Study<\/span><\/div>\n
A new FDA-cleared AI tool (Vivio System) helps detect heart failure (HF) early \u2014 directly during primary care visits \u2014 before patients show severe symptoms.<\/div>\n
2. Problem with Current HF Diagnosis<\/span><\/div>\n
Most HF cases are diagnosed late in ER or hospital, with advanced symptoms. Early diagnosis is key to better outcomes and easier management.<\/div>\n
3. How the Vivio AI System Works<\/span><\/div>\n
\u2022 It uses a standard blood pressure cuff + a single-lead Bluetooth ECG.<\/span><\/div>\n
\u2022 No imaging (like echo) is required.<\/span><\/div>\n
\u2022 No manual data entry by the doctor is needed.<\/span><\/div>\n
\u2022 The built-in AI algorithm analyzes real-time physiologic signals to estimate left ventricular end-diastolic pressure (LVEDP), which is a gold-standard HF marker.<\/span><\/div>\n
\u2022 The test takes only 5 minutes and can be done during a routine clinic visit.<\/span><\/div>\n
4. Who Was Screened<\/span><\/div>\n
\u2022 The study involved 2,040 patients aged \u226565 with diabetes or chronic kidney disease.<\/span><\/div>\n
\u2022 38.5% had elevated LVEDP (early sign of HF).<\/span><\/div>\n
\u2022 Those patients then completed a quality-of-life questionnaire (KCCQ-12).<\/span><\/div>\n
5. Results<\/span><\/div>\n
\u2022 Nearly 25% of patients with high LVEDP had symptoms consistent with NYHA Class II\u2013IV heart failure \u2014 despite not being diagnosed before.<\/span><\/div>\n
\u2022 Women were diagnosed more often than men, echoing past studies about delayed HF diagnosis in women.<\/span><\/div>\n
6. Clinical Significance<\/span><\/div>\n
\u2022 Combining AI-based LVEDP detection with KCCQ questionnaires can catch HF early and prompt faster treatment.<\/span><\/div>\n
\u2022 Most patients were not asymptomatic, showing real-world potential to reduce ER visits and improve quality of life.<\/span><\/div>\n
7. Why This Matters for Primary Care<\/span><\/div>\n
\u2022 Many primary care providers miss early HF due to vague symptoms or comorbidities.<\/span><\/div>\n
\u2022 This tool offers a quick, noninvasive, and scalable solution that fits easily into primary care workflow.<\/span><\/div>\n
8. System Benefits<\/span><\/div>\n
\u2022 Over 15,000 tests already performed in the U.S. since FDA clearance (October 2023).<\/span><\/div>\n
\u2022 Clinics using Vivio AI report:<\/span><\/div>\n
\u2022 Higher rates of first-time HF diagnosis<\/span><\/div>\n
\u2022 Reduced hospital admissions<\/span><\/div>\n
\u2022 Better medication adherence<\/span><\/div>\n
\u2022 Improved patient follow-up<\/span><\/div>\n
9. Key Insight<\/span><\/div>\n
\u2022 Vivio AI does not require heart imaging like echocardiograms.<\/span><\/div>\n
\u2022 No manual input of clinical data or symptoms is needed.<\/span><\/div>\n
\u2022 Non-specialists (GPs, nurses) can easily operate the system.<\/span><\/div>\n
\u2022 It opens the door for wider HF screening in community settings and developing countries.<\/span><\/div>\n
<\/div>\n
https:\/\/www.ventrichealth.com\/vivio<\/div>\n
<\/div>\n
https:\/\/www.jacc.org\/doi\/10.1016\/j.jacadv.2025.102002<\/div>\n","protected":false},"excerpt":{"rendered":"

AI Enables Early Heart Failure Screening in Primary Care Published: August 4, 2025 (Based on original research published in JACC: Advances) Summary: 1. Purpose of the Study A new FDA-cleared AI tool (Vivio System) helps detect heart failure (HF) early \u2014 directly during primary care visits \u2014 before patients show severe symptoms. 2. Problem with […]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8287","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=8287"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8287\/revisions"}],"predecessor-version":[{"id":8288,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8287\/revisions\/8288"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=8287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=8287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=8287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}